Clin2
NCT07189299Possibly a fitNot yet recruiting

Low-dose LSD for premenstrual mood and physical symptoms

PMSPMDD

Treatments studied

Part of Mental health, Women’s health & pregnancy clinical trials.

This study tests whether taking a very small dose (microdose) of LSD twice a week helps reduce the mood and physical symptoms of PMDD and severe PMS. You would take the study drug or a placebo during the luteal phase (the week before your period) to see if it improves how you feel.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old and have regular menstrual cycles (usually 21 to 35 days).
  • You must have PMDD or severe PMS, confirmed by mood and physical symptoms that show up in the week before your period and go away after it starts.
  • You must not be currently taking medicine or using hormonal birth control for your PMS/PMDD (if using oral contraceptives, you must have stopped at least 6 months ago).
  • You must not have had any serious mental health conditions like bipolar disorder, schizophrenia, or severe depression with hallucinations, and no family history of schizophrenia.
  • You must be willing to avoid driving or heavy machinery on days you take the study drug, and limit alcohol, cigarettes, and any other substances.
  • You must be able to speak and understand German well enough to follow study instructions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06130371Recruiting
Stress, Inflammation & Brain in Depression vs. Severe PMS

This study looks at how stress and inflammation affect the brain in women with major depression compared to women with severe PMS (PMDD). It could help find better ways to understand and treat these mood disorders.

Tübingen, Baden-Wurttemberg
NCT07818720Not yet recruiting· Phase 1
Study of an experimental drug for severe PMS (PMDD)

This study tests an experimental medicine for premenstrual dysphoric disorder (PMDD), a severe form of PMS. It is a phase 1 trial, so the main goal is to check the drug's safety and how your body handles it, but it may also help assess its effectiveness.

NCT06771583Recruiting
Finding biomarkers for PMDD in blood samples

This study looks for chemical markers in the blood that might help diagnose PMDD. It involves blood draws and questionnaires over one or two menstrual cycles to see how your body responds to natural hormone changes.

Baltimore, Maryland
NCT07771426Not yet recruiting
Comparing people with premenstrual dysphoric disorder to healthy volunteers

This study looks at premenstrual dysphoric disorder (PMDD) and compares people who have it to healthy controls. It may help researchers understand the condition better and could lead to improved treatments.

London, 'London
NCT07554950Not yet recruiting
Sleep and education workshop for PMDD

This study tests whether a workshop that teaches about premenstrual dysphoric disorder (PMDD) and sleep can help women and individuals with PMDD who also have sleep problems. It aims to improve sleep and overall well-being.

Hamilton, Ontario
NCT07686718Recruiting
Hormone patterns in PMDD vs. healthy controls

This study compares hormone levels during the luteal phase (the time between ovulation and your period) in people with PMDD versus those without symptoms. It involves collecting a blood sample mid-luteal phase to better understand what causes PMDD.

Lancaster, Lancashire

Hear when a new PMDD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.